Ginkgo Bioworks Holdings, Inc.
DNA
$7.54
-$0.27-3.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -107.53M | -56.40M | -217.18M | -165.91M | -211.69M |
| Total Depreciation and Amortization | 15.65M | 17.17M | 17.33M | 12.87M | 12.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.27M | 33.77M | 109.58M | 63.47M | 98.97M |
| Change in Net Operating Assets | 2.18M | -98.04M | 5.88M | 312.00K | 42.06M |
| Cash from Operations | -42.44M | -103.50M | -84.39M | -89.26M | -57.83M |
| Capital Expenditure | -13.71M | -15.09M | -27.03M | -6.71M | -3.45M |
| Sale of Property, Plant, and Equipment | 57.00K | 400.00K | 191.00K | -- | 1.43M |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -5.40M | -- |
| Divestitures | -- | -- | -- | -- | -42.98M |
| Other Investing Activities | 568.00K | 4.49M | -- | -- | -1.68M |
| Cash from Investing | -13.09M | -10.20M | -26.84M | -12.11M | -46.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -203.00K | -200.00K | -200.00K | -294.00K | -318.00K |
| Issuance of Common Stock | 0.00 | 0.00 | 14.00K | 70.00K | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -23.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -265.00K | -40.00K | -621.00K | -305.00K |
| Cash from Financing | -203.00K | -465.00K | -226.00K | -845.00K | -632.00K |
| Foreign Exchange rate Adjustments | -73.00K | -35.00K | -16.00K | -157.00K | 102.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.80M | -114.20M | -111.47M | -102.37M | -105.04M |
